LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Profit Margin

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s profit margin stands at -75.61% as of March 2024. That is below the sector sector average of 22.52%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) sits lower the its sector benchmark (22.52%) with a profit margin of -75.61%. That is roughly 435.7% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of -75.61% for LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s profit margin evolved across reporting periods, while the comparison chart places YSBPW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.